Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995–2015

Renoux, Christel, Shin, Ju‐Young, Dell'Aniello, Sophie, Fergusson, Emma, Suissa, Samy·2016·British Journal of Clinical Pharmacology

Cited by (132)

Items 101–132 of 132

  1. Advancing a Global Public Health Response to Violence
    Richard Whittington, James McGuire, Maria Fernanda Tourinho Peres · 2020 · Cambridge University Press eBooks
  2. Rewiring Our Expectations
    Richard Whittington, James McGuire, Maria Fernanda Tourinho Peres · 2020 · Cambridge University Press eBooks
  3. Changing Structures
    Richard Whittington, James McGuire, Maria Fernanda Tourinho Peres · 2020 · Cambridge University Press eBooks
  4. Risk Assessment
    Richard Whittington, James McGuire, Maria Fernanda Tourinho Peres · 2020 · Cambridge University Press eBooks
  5. The Roots of Human Violence
    Richard Whittington, James McGuire, Maria Fernanda Tourinho Peres · 2020 · Cambridge University Press eBooks
  6. Index
    Richard Whittington, James McGuire, Maria Fernanda Tourinho Peres · 2020 · Cambridge University Press eBooks
  7. Electroencephalogram activity in attention-deficit hyperactivity disorder
    MaiA Shalaby, LamyaaG. E. Elhamrawya, MohamedS Abdel-Shafy · 2022 · Menoufia Medical Journal
  8. Psychopharmacology for Pediatric ADHD
    Lauren T. Schumacher, Laurence Lee Greenhill · 2024 · Springer eBooks
  9. Does Dexamphetamine Cause Addiction? A Narrative Review
    Hazer Khalifa, Emily Hibbert, Natalie Gauci, Alison Sally Poulton · 2025 · Psychoactives
  10. Maternal and Neonatal Outcomes Associated with the use of Dexamphetamine or Methylphenidate in Pregnancy: A Retrospective Cohort Study
    Amina Rhaman, Caitlin S. Wyrwoll, Danielle Jane Russell, David Brian Preen, Erin A. Kelty · 2025 · Neurodiversity
  11. Paternal exposure to methylphenidate causes behavioral abnormalities in grandchildren
    Ryota Nakano, Riko Ikeda, Yoshitaka Yamazaki, Sakiko Munetomo-Aoki, Haruka Morinaka, Shohei Abe, Hikaru Isobe, Masahiro Hosonuma, Shotaro Kamijo, Asuka Kaizaki‐Mitsumoto et al. · 2025 · The Journal of Toxicological Sciences
  12. Attention‐deficit hyperactivity disorder in children and young persons during the COVID‐19 pandemic. A temporal trends analysis of electronic heath records in Greater Manchester, England
    Louise Jane Hussey, Evangelos Kontopantelis, Pearl L. H. Mok, Darren Mark Ashcroft, Shruti Garg, Carolyn Anne Chew-Graham, Karina Lovell, Roger Thomas Webb · 2025 · JCPP Advances
  13. Outpatient prescription patterns of attention deficit hyperactivity disorder medications in Tabriz Iran 2021 to 2022
    Ali Fakhari, Mostafa Farahbakhsh, Ali Azimian, Amin Khameneh, Mahsa Matinkia, Ehsan Aghajani · 2025 · Research Square
  14. Use of methylphenidate and the risk of cardiovascular diseases in children and adolescents with a family history of heart diseases and congenital heart diseases: A self-controlled case series study
    Min‐Jing Lee, Chien‐Wei Huang, Tai‐Hsin Hung, Yi‐Lung Chen, Vincent Chin‐Hung Chen · 2025 · European Child & Adolescent Psychiatry
  15. Sociodemographic and geographical variation in prescribing psychotropic drugs to children and young people with common mental disorders and Attention Deficit Hyperactive Disorders in North West London: population-based study
    Antonio Ivan Lazzarino, Stephen Russell Naulls, Rinad Bakhti, Steven Hope, Dasha Nicholls, Michaela Otis, Tamsin Robinson, Shamini Gnani, Dougal S. Hargreaves · 2025 · BMJ Open
  16. Additional file 4 of Temporal trends in annual incidence rates for psychiatric disorders and self-harm among children and adolescents in the UK, 2003–2018
    Cybulski, Lukasz, Darren Mark Ashcroft, Matthew Carr, Shruti Garg, Carolyn Anne Chew-Graham, Navneet Kapur, Roger Thomas Webb · 2021 · Figshare
  17. Additional file 1 of Trialling a microbiome-targeted dietary intervention in children with ADHD—the rationale and a non-randomised feasibility study
    Kate Lawrence, Kyriaki Myrissa, Miguel A Toribio-Mateas, Minini, Lori, Alice M. Gregory · 2022 · Figshare
  18. Additional file 6 of Temporal trends in annual incidence rates for psychiatric disorders and self-harm among children and adolescents in the UK, 2003–2018
    Cybulski, Lukasz, Darren Mark Ashcroft, Matthew Carr, Shruti Garg, Carolyn Anne Chew-Graham, Navneet Kapur, Roger Thomas Webb · 2021 · Figshare
  19. Additional file 1 of Temporal trends in annual incidence rates for psychiatric disorders and self-harm among children and adolescents in the UK, 2003–2018
    Cybulski, Lukasz, Darren Mark Ashcroft, Matthew Carr, Shruti Garg, Carolyn Anne Chew-Graham, Navneet Kapur, Roger Thomas Webb · 2021 · Figshare
  20. Additional file 8 of Inequalities in children’s mental health care: analysis of routinely collected data on prescribing and referrals to secondary care
    William Ball, Corri Black, Sharon Gordon, Bārbala Ostrovska, Shantini Paranjothy, Adelene D. Rasalam, David Ritchie, Rowlands, Helen, Rzewuska, Magdalena, Elaine Thompson et al. · 2023 · Figshare
  21. Additional file 6 of Inequalities in children’s mental health care: analysis of routinely collected data on prescribing and referrals to secondary care
    William Ball, Corri Black, Sharon Gordon, Bārbala Ostrovska, Shantini Paranjothy, Adelene D. Rasalam, David Ritchie, Rowlands, Helen, Rzewuska, Magdalena, Elaine Thompson et al. · 2023 · Figshare
  22. Additional file 7 of Inequalities in children’s mental health care: analysis of routinely collected data on prescribing and referrals to secondary care
    William Ball, Corri Black, Sharon Gordon, Bārbala Ostrovska, Shantini Paranjothy, Adelene D. Rasalam, David Ritchie, Rowlands, Helen, Rzewuska, Magdalena, Elaine Thompson et al. · 2023 · Figshare
  23. Additional file 3 of Temporal trends in annual incidence rates for psychiatric disorders and self-harm among children and adolescents in the UK, 2003–2018
    Cybulski, Lukasz, Darren Mark Ashcroft, Matthew Carr, Shruti Garg, Carolyn Anne Chew-Graham, Navneet Kapur, Roger Thomas Webb · 2021 · Figshare
  24. Attention Deficit Hyperactivity Disorder (ADHD)
    Jane A. Sedgwick-Müller, Ulrich Müller-Sedgwick · 2025 · Springer eBooks
  25. Surveillance de l'abus de médicaments via le comportement de doctor shopping
    Thomas Soeiro · 2021
  26. The exponential increase in the number of prescriptions for ADHD medication between 2012 and 2022 in Poland in patients aged 5–59 years: a pharmacoepidemiological study
    Marcin Rzeszutek, Łukasz Konowałek, Joanna Martin, Agnieszka Butwicka, Tomasz Wolańczyk · 2026 · European Child & Adolescent Psychiatry
  27. Trends in methylphenidate dispensing and regional inequalities among children and adolescents in France around the 2021 prescription reform: a repeated cross-sectional ecological analysis of national data (2014–2024)
    Edouard Guez, Judith E.B. van der Waerden, David Cohen, Xavier Benarous · 2026 · BMC Public Health
  28. Attention Deficit Hyperactivity Disorder (ADHD)
    Jane A. Sedgwick-Müller, Ulrich Müller-Sedgwick · 2026 · Springer eBooks
  29. Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults
    Dilyara Nurkhametova, Ekaterina V. Yudina, Yinghui Wei, Tatyana Rudolfovna Abakumova, Лилия Евгеньевна Зиганшина · 2026 · International Journal of Risk & Safety in Medicine
  30. Effects of ADHD Medications on Male Reproductive Function: A Systematic Review of In Vivo Mammalian Evidence
    Kacper Wojtysiak, Zuzanna Ratka, Agnieszka Chłopaś‐Konowałek · 2026 · International Journal of Molecular Sciences
  31. Trends and Gender Disparities in Medical Narcotics Utilization in South Korea: A Nationwide Population‐Based Study, 2019–2023
    Jin Hwan Kim, Jonghun Kim, Saerom Kim · 2026 · Pharmacoepidemiology and Drug Safety
  32. Paternal methylphenidate exposure alters sperm miRNAs and induces intergenerational behavioral and transcriptional changes that are largely reversed by washout
    Kanata Akaike, Asuka Kaizaki‐Mitsumoto, Satoshi Numazawa · 2026 · Toxicological Sciences